Systemic EMD 68843 injections reduce anxiety in the shock-probe, but not the plus-maze test

European Journal of Pharmacology

Volumn 414, Issue 2-3, 2001, Pages 245-248

  Treit, Dallas ^a   Degroot, Aldemar ^a   Kashluba, Shauna ^a   Bartoszyk, Gerd D ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MERCK KGAA   (Germany)

Author keywords

5 HT (5 hydroxytryptamine, serotonin) reuptake inhibitor; 5 HT1A receptor agonist; Anxiety; EMD 68843; Selective

Indexed keywords

BENZOFURAN DERIVATIVE; DIAZEPAM; DRUG VEHICLE; PIPERAZINE DERIVATIVE; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VILAZODONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BENZOFURANS; DIAZEPAM; ELECTRIC STIMULATION; INDOLES; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN UPTAKE INHIBITORS;

EID: 0035793968     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)00799-3     Document Type: Article

References (23)

1. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study
2. 1A receptor: Signaling, desensitization, and gene transcription
3. 1A agonist EMD 68843
4. 1A receptor agonistic properties
5. A role for the serotonin system in the mechanism of action of antidepressant treatments: Preclinical evidence
6. Shock-induced ultrasonic vocalization in young adult rats: A model for testing putative anti-anxiety drugs
7. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis in SHR and WKY rats
8. Presynaptic serotonin receptor-mediated response in mice attenuated by antidepressant drugs and electroconvulsive shock
9. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders
10. 5-Hydroxytryptamine pathways in anxiety and its treatment
11. (-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine
12. 1A autoreceptors in the action of selective serotonin reuptake inhibitors
13. Development of tolerance to 8-OH-DPAT induced blockade of acquisition of a positive avoidance response
14. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat dorsal raphe nucleus?
15. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo
16. 1A receptor agonist 8-OH-DPAT
17. The effects of cholecystokinin A and B receptor antagonists, devazepide and L 365260, on citalopram-induced decrease of exploratory behaviour in rat
18. A comparison of the effects of 8-OH-DPAT pretreatment on different behavioural responses to 8-OH-DPAT
19. Validation of open: Closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
20. Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality
21. The non-competitive NMDA receptor antagonist(+) MK801 counteracts the long-lasting attenuation of the hypothermic response induced by acute doses of 8-OH-DPAT in the rat
22. A comparison of anxiolytic and nonanxiolytic agents in the shock-probe burying test for anxiolytics
23. Anxiogenic stimuli in the elevated plus-maze